Top Markets
#1 Pleasing Gold Pleasing Gold +1,546.27%
#2 PulseChain PulseChain +55.72%
#3 Ontology Gas Ontology Gas +36.94%
#4 DogBull DogBull +36.89%
#5 BOOK OF MEME BOOK OF MEME +30.55%
#6 Neiro Neiro +21.85%
#7 Collect on Fanable Collect on Fanable +21.43%
#8 Nockchain Nockchain +19.56%
#9 Pump.fun Pump.fun +19.14%
#10 Unit Pump Unit Pump +19.14%
Coin of the day
Pleasing Gold Pleasing Gold
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Classement en actions #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Prix de l'action
$0.12164306
Dernière synchronisation: 2024-11-11
Capitalisation boursière
$38.53M
Changement (1 jour)
-4.14%
Changement (1 an)
0.00%
Pays
AU
Échange PharmAust Limited (PAA)

Catégorie

Healthcare
Ratio P/S pour PharmAust Limited (PAA)
Ratio P/S au August 2026 TTM : 0.00
Selon les derniers rapports financiers et le cours de l'action de PharmAust Limited, le ratio cours/ventes actuel (TTM) est 0.00. À la fin de 2024, le ratio P/S était de 0.00.
Historique du ratio P/S pour PharmAust Limited de 2001 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
2026 (TTM) 0.00 0.00%
2025 0.00 0.00%
2024 0.00 -100.00%
2023 8.53 29.96%
2022 6.56 -51.13%
2021 13.42 -6.50%
2020 14.36 611.37%
2019 2.02 20.63%
2018 1.67 -19.73%
2017 2.08 -15.55%
2016 2.47 -36.92%
2015 3.91 -40.73%
2014 6.60 108.20%
2013 3.17 87.09%
2012 1.70 -67.92%
2011 5.28 -58.41%
2010 12.70 360.27%
2009 2.76 66.79%
2008 1.65 66.92%
2007 0.99 -42.02%
2006 1.71 -41.66%
2005 2.93 -80.04%
2004 14.68 -38.19%
2003 23.75 159.55%
2002 9.15 0.00%
2001 0.00 0.00%
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH